Davidson Kempner Capital Management’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-366,671
| Closed | -$532K | – | 314 |
|
|
2024
Q1 | $532K | Hold |
366,671
| – | – | 0.01% | 164 |
|
|
2023
Q4 | $36.6K | Hold |
366,671
| – | – | ﹤0.01% | 170 |
|
|
2023
Q3 | $55K | Hold |
366,671
| – | – | ﹤0.01% | 172 |
|
|
2023
Q2 | $27.5K | Hold |
366,671
| – | – | ﹤0.01% | 208 |
|
|
2023
Q1 | $18.7K | Hold |
366,671
| – | – | ﹤0.01% | 265 |
|
|
2022
Q4 | $11K | Hold |
366,671
| – | – | ﹤0.01% | 331 |
|
|
2022
Q3 | $18K | Hold |
366,671
| – | – | ﹤0.01% | 409 |
|
|
2022
Q2 | $55K | Hold |
366,671
| – | – | ﹤0.01% | 376 |
|
|
2022
Q1 | $103K | Hold |
366,671
| – | – | ﹤0.01% | 424 |
|
|
2021
Q4 | $187K | Hold |
366,671
| – | – | ﹤0.01% | 417 |
|
|
2021
Q3 | $205K | Hold |
366,671
| – | – | ﹤0.01% | 375 |
|
|
2021
Q2 | $367K | Buy |
+366,671
| New | +$367K | ﹤0.01% | 428 |
|